Mechanisms of Radiation-Induced Innate Immune Dysfunction and Its Countermeasures

辐射引起的先天性免疫功能障碍的机制及对策

基本信息

  • 批准号:
    10669714
  • 负责人:
  • 金额:
    $ 75.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-07-21 至 2027-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT DESCRIPTION: Nuclear power plant accidents, terrorism, and geopolitical instability present the risk of massive radiation exposure. As neutrophils markedly decline post-radiation exposure, macrophages assume the important role of removing most translocated or invading bacteria. However, very few studies have evaluated the effects of radiation on the phagocytic function of differentiated, non-dividing tissue resident macrophages. We have discovered that extracellular cold-inducible RNA-binding protein (eCIRP) is a novel mediator which can cause innate immune dysfunction. In our preliminary studies, we have shown an increased release of eCIRP after radiation exposure in vivo and in vitro. Deficiency in CIRP improved the survival of mice subjected to total body irradiation (TBI). Sepsis significantly worsened the survival post-TBI, but CIRP-/- mice had lower bacterial loads and improved survival after sepsis, suggesting that eCIRP’s detrimental effect may be due to the impaired bacterial clearance. Indeed, eCIRP significantly reduced macrophage phagocytosis of E. coli via cytoskeletal paralysis. eCIRP also induced the formation of macro- phage extracellular traps, and extracellular traps reduced macrophage phagocytosis of dying cells. We have identified that triggering receptor expressed on myeloid cells-1 (TREM-1) is the eCIRP receptor, and that TREM-1 activation plays a critical role in the eCIRP-mediated macrophage phagocytic dysfunction. Moreover, the 30-day survival after TBI was significantly improved in TREM-1-/- mice. Based on these novel findings, we hypothesize that eCIRP released after ionizing radiation activates TREM-1, resulting in macrophage phagocytic dysfunction and ultimately leading to sepsis and death. We have also shown that the new inhibitor M3 reduced eCIRP’s binding to TREM-1 and improved survival after sepsis. As such, we further hypothesize that inhibition of eCIRP/TREM-1 interaction with M3 restores macrophage phagocytic function, thereby improving the survival of mice subjected to radiation injury alone or complicated by sepsis. In this project, we plan to further establish the critical role of eCIRP on radiation-induced macrophage phagocytic dysfunction, determine the mechanisms by which eCIRP causes macrophage phagocytic dysfunction, and develop M3 as a novel radiation medical countermeasure targeting eCIRP-induced macrophage phagocytic dysfunction. These studies shall provide novel mechanistic insights into the pathogenesis of radiation-induced innate immune dysfunction, as well as a new medical countermeasure for victims of major radiation exposure with or without sepsis.
项目描述:核电站事故、恐怖主义和地缘政治不稳定带来了 大量辐射暴露的风险。由于中性粒细胞在辐射暴露后显着下降,巨噬细胞 承担清除大多数易位或入侵细菌的重要作用。但研究却很少 评估了辐射对分化、非分裂组织居民吞噬功能的影响 巨噬细胞。我们发现细胞外冷诱导RNA结合蛋白(eCIRP)是一种新型的 可导致先天性免疫功能障碍的介质。在我们的初步研究中,我们已经表明 体内和体外辐射暴露后 eCIRP 的释放增加。 CIRP 的缺陷改善了 接受全身照射(TBI)的小鼠的存活率。脓毒症显着恶化了 TBI 后的生存率, 但 CIRP-/- 小鼠的细菌载量较低,脓毒症后存活率提高,这表明 eCIRP 的 有害影响可能是由于细菌清除受损所致。事实上,eCIRP 显着降低了 巨噬细胞通过细胞骨架麻痹吞噬大肠杆菌。 eCIRP 还诱导了宏的形成 噬菌体细胞外陷阱,细胞外陷阱减少了巨噬细胞对垂死细胞的吞噬作用。我们有 确定髓样细胞 1 (TREM-1) 上表达的触发受体是 eCIRP 受体,并且 TREM-1 激活在 eCIRP 介导的巨噬细胞吞噬功能障碍中发挥着关键作用。而且, TREM-1-/- 小鼠 TBI 后 30 天的存活率显着提高。基于这些新颖的发现,我们 假设电离辐射激活 TREM-1 后释放的 eCIRP,导致巨噬细胞 吞噬细胞功能障碍,最终导致败血症和死亡。我们还表明,新的抑制剂 M3 减少了 eCIRP 与 TREM-1 的结合,并提高了脓毒症后的生存率。因此,我们进一步假设 抑制 eCIRP/TREM-1 与 M3 的相互作用可恢复巨噬细胞的吞噬功能,从而 提高单独遭受放射损伤或并发败血症的小鼠的存活率。在这个项目中,我们 计划进一步确定 eCIRP 对辐射引起的巨噬细胞吞噬功能障碍的关键作用, 确定 eCIRP 导致巨噬细胞吞噬功能障碍的机制,并将 M3 开发为 针对 eCIRP 诱导的巨噬细胞吞噬功能障碍的新型放射医学对策。这些 研究将为辐射诱导的先天免疫的发病机制提供新的机制见解 功能障碍,以及针对有或没有严重辐射暴露的受害者的新医疗对策 败血症。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Radiation upregulates macrophage TREM-1 expression to exacerbate injury in mice.
  • DOI:
    10.3389/fimmu.2023.1151250
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Monowar Aziz其他文献

Monowar Aziz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Monowar Aziz', 18)}}的其他基金

Mechanisms of Radiation-Induced Innate Immune Dysfunction and Its Countermeasures
辐射引起的先天性免疫功能障碍的机制及对策
  • 批准号:
    10474023
  • 财政年份:
    2022
  • 资助金额:
    $ 75.19万
  • 项目类别:
Neutrophils in Sepsis: Role of CIRP
脓毒症中的中性粒细胞:CIRP 的作用
  • 批准号:
    10429996
  • 财政年份:
    2018
  • 资助金额:
    $ 75.19万
  • 项目类别:
Neutrophils in Sepsis: Role of CIRP
脓毒症中的中性粒细胞:CIRP 的作用
  • 批准号:
    10197957
  • 财政年份:
    2018
  • 资助金额:
    $ 75.19万
  • 项目类别:
Neutrophils in Sepsis: Role of CIRP
脓毒症中的中性粒细胞:CIRP 的作用
  • 批准号:
    9767826
  • 财政年份:
    2018
  • 资助金额:
    $ 75.19万
  • 项目类别:
Neutrophils in Sepsis: Role of CIRP
脓毒症中的中性粒细胞:CIRP 的作用
  • 批准号:
    9580383
  • 财政年份:
    2018
  • 资助金额:
    $ 75.19万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 75.19万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 75.19万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 75.19万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 75.19万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 75.19万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 75.19万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 75.19万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 75.19万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 75.19万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 75.19万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了